Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infection
This study has been completed.
Study NCT01273948   Information provided by Peregrine Pharmaceuticals

First Received on January 7, 2011.   Last Updated on February 2, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial